Renaissance Technologies (RenTech)'s BDMD Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 55,371 shares of Baird Medical Investment Holdings Limited (BDMD) worth $63,677, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in BDMD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Baird Medical Investment Holdings Limited (BDMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Baird Medical Investment Holdings Limited (BDMD) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +55,371 | New Buy | 55,371 | $1.15 |
Renaissance Technologies (RenTech)'s Baird Medical Investment Holdings Limited Investment FAQs
Renaissance Technologies (RenTech) first purchased Baird Medical Investment Holdings Limited (BDMD) in Q2 2026, acquiring 55,371 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Baird Medical Investment Holdings Limited (BDMD) for 1 quarters since Q2 2026.
Renaissance Technologies (RenTech)'s largest addition to Baird Medical Investment Holdings Limited (BDMD) was in Q2 2026, adding 55,371 shares worth $63,677.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 55,371 shares of Baird Medical Investment Holdings Limited (BDMD), valued at approximately $63,677.
As of the Q2 2026 filing, Baird Medical Investment Holdings Limited (BDMD) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Baird Medical Investment Holdings Limited (BDMD) was 55,371 shares, as reported at the end of Q2 2026.